STAGE III HEPATOCELLULAR CARCINOMA AJCC V7
Clinical trials for STAGE III HEPATOCELLULAR CARCINOMA AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE III HEPATOCELLULAR CARCINOMA AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE III HEPATOCELLULAR CARCINOMA AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Proton beam vs X-Ray: which radiation is better for liver cancer?
Disease control OngoingThis study compares two types of radiation therapy for people with liver cancer that cannot be removed by surgery or has come back. One type uses standard X-rays (photons), while the other uses proton beams, which may cause less harm to healthy organs nearby. The goal is to see i…
Matched conditions: STAGE III HEPATOCELLULAR CARCINOMA AJCC V7
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 17, 2026 03:08 UTC
-
New drug combo targets tough cancers: hope for liver, pancreas, and bile duct tumors
Disease control OngoingThis early-phase study tests a combination of two drugs, guadecitabine and durvalumab, in people with advanced liver, pancreatic, bile duct, or gallbladder cancer that has spread. The main goals are to find the safest dose and see if the drugs can shrink tumors. About 55 particip…
Matched conditions: STAGE III HEPATOCELLULAR CARCINOMA AJCC V7
Phase: PHASE1 • Sponsor: University of Southern California • Aim: Disease control
Last updated May 12, 2026 13:42 UTC